NextCell Pharma AB (OSTO:NXTCL) Debt-to-Equity : 0.00 (As of Feb. 2025)

NextCell Pharma AB Debt-to-Equity Chart

NextCell Pharma AB Annual Data
	Trend	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23	Aug24
Debt-to-Equity		Get a 7-Day Free Trial					-	-	-	-	-

NextCell Pharma AB Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Debt-to-Equity	Get a 7-Day Free Trial															N/A	-	-	-	-

Competitive Comparison of NextCell Pharma AB's Debt-to-Equity

For the Biotechnology subindustry, NextCell Pharma AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NextCell Pharma AB's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NextCell Pharma AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where NextCell Pharma AB's Debt-to-Equity falls into.

NextCell Pharma AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

NextCell Pharma AB's Debt to Equity Ratio for the fiscal year that ended in Aug. 2024 is calculated as

NextCell Pharma AB's Debt to Equity Ratio for the quarter that ended in Feb. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NextCell Pharma AB  (OSTO:NXTCL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

NextCell Pharma AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

NextCell Pharma AB Business Description